![PDF) Risk of SARS‐CoV ‐2 infection, hospitalization, and death for COVID ‐19 in people with Parkinson disease or parkinsonism over a 15‐month period: A cohort study PDF) Risk of SARS‐CoV ‐2 infection, hospitalization, and death for COVID ‐19 in people with Parkinson disease or parkinsonism over a 15‐month period: A cohort study](https://i1.rgstatic.net/publication/362053682_Risk_of_SARS-CoV_-2_infection_hospitalization_and_death_for_COVID_-19_in_people_with_Parkinson's_disease_or_parkinsonism_over_a_15-month_period_a_cohort_study/links/62eaa2a2505511283e89c998/largepreview.png)
PDF) Risk of SARS‐CoV ‐2 infection, hospitalization, and death for COVID ‐19 in people with Parkinson disease or parkinsonism over a 15‐month period: A cohort study
![Can We Treat Neurodegenerative Proteinopathies by Enhancing Protein Degradation? - Engelender - Movement Disorders - Wiley Online Library Can We Treat Neurodegenerative Proteinopathies by Enhancing Protein Degradation? - Engelender - Movement Disorders - Wiley Online Library](https://movementdisorders.onlinelibrary.wiley.com/cms/asset/4b761525-662e-4f0a-9752-f32704e8bfea/mds.v37.6.cover.jpg)
Can We Treat Neurodegenerative Proteinopathies by Enhancing Protein Degradation? - Engelender - Movement Disorders - Wiley Online Library
Implications of Successful Symptomatic Treatment in Parkinson's Disease for Therapeutic Strategies of Alzheimer's Disease | ACS Chemical Neuroscience
![Amazon.com : GYENNO Parkinson Spoon and Fork for hand tremo, all kinds of meal 360 degree stabilization solution, offsetting 85% unwanted tremor : Health & Household Amazon.com : GYENNO Parkinson Spoon and Fork for hand tremo, all kinds of meal 360 degree stabilization solution, offsetting 85% unwanted tremor : Health & Household](https://m.media-amazon.com/images/I/31-lY0Dc2dL._AC_SY1000_.jpg)
Amazon.com : GYENNO Parkinson Spoon and Fork for hand tremo, all kinds of meal 360 degree stabilization solution, offsetting 85% unwanted tremor : Health & Household
Proteomic characterization of secretory granules in dopaminergic neurons indicates chromogranin/secretogranin-mediated protein processing impairment in Parkinson's disease | Aging
![JPM | Free Full-Text | Are Parkinson's Disease Patients the Ideal Preclinical Population for Alzheimer's Disease Therapeutics? JPM | Free Full-Text | Are Parkinson's Disease Patients the Ideal Preclinical Population for Alzheimer's Disease Therapeutics?](https://www.mdpi.com/jpm/jpm-11-00834/article_deploy/html/images/jpm-11-00834-g001-550.jpg)
JPM | Free Full-Text | Are Parkinson's Disease Patients the Ideal Preclinical Population for Alzheimer's Disease Therapeutics?
![Frontiers | Methodological Issues in Randomized Clinical Trials for Prodromal Alzheimer's and Parkinson's Disease Frontiers | Methodological Issues in Randomized Clinical Trials for Prodromal Alzheimer's and Parkinson's Disease](https://www.frontiersin.org/files/Articles/694329/fneur-12-694329-HTML/image_m/fneur-12-694329-t001.jpg)
Frontiers | Methodological Issues in Randomized Clinical Trials for Prodromal Alzheimer's and Parkinson's Disease
![Stiff man syndrome and related conditions - Meinck - 2002 - Movement Disorders - Wiley Online Library Stiff man syndrome and related conditions - Meinck - 2002 - Movement Disorders - Wiley Online Library](https://movementdisorders.onlinelibrary.wiley.com/cms/asset/2b2b5c0d-8dd9-4d28-8b4a-ecbe019cbf00/mds.v37.12.cover.jpg)
Stiff man syndrome and related conditions - Meinck - 2002 - Movement Disorders - Wiley Online Library
![A Proposed Roadmap for Parkinson's Disease Proof of Concept Clinical Trials Investigating Compounds Targeting Alpha-Synuclein - IOS Press A Proposed Roadmap for Parkinson's Disease Proof of Concept Clinical Trials Investigating Compounds Targeting Alpha-Synuclein - IOS Press](https://content.iospress.com/media/jpd/2019/9-1/jpd-9-1-jpd181471/jpd-9-jpd181471-g001.jpg?width=755)
A Proposed Roadmap for Parkinson's Disease Proof of Concept Clinical Trials Investigating Compounds Targeting Alpha-Synuclein - IOS Press
![Replacing what's lost: a new era of stem cell therapy for Parkinson's disease | Translational Neurodegeneration | Full Text Replacing what's lost: a new era of stem cell therapy for Parkinson's disease | Translational Neurodegeneration | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs40035-019-0180-x/MediaObjects/40035_2019_180_Fig1_HTML.png)
Replacing what's lost: a new era of stem cell therapy for Parkinson's disease | Translational Neurodegeneration | Full Text
![Therapeutic Efficacy of Plasmalogens for Alzheimer's Disease, Mild Cognitive Impairment, and Parkinson's Disease in Conjunction with a New Hypothesis for the Etiology of Alzheimer's Disease | SpringerLink Therapeutic Efficacy of Plasmalogens for Alzheimer's Disease, Mild Cognitive Impairment, and Parkinson's Disease in Conjunction with a New Hypothesis for the Etiology of Alzheimer's Disease | SpringerLink](https://media.springernature.com/lw685/springer-static/image/chp%3A10.1007%2F978-3-030-60204-8_14/MediaObjects/484675_1_En_14_Fig6_HTML.png)